Medicine:Digital Mammographic Imaging Screening Trial
The Digital Mammographic Imaging Screening Trial (DMIST) is a multi-institutional research study, beginning in 2001, on the efficacy for screening of full-field digital mammography (FFDM) compared to conventional film-screen mammography that was sponsored by the U.S. National Cancer Institute and performed by the American College of Radiology Imaging Network (ACRIN).[1] The findings[2][3] that FFDM was not inferior to the existing technology, and potentially superior in younger women with dense breasts, has led to a rapid proliferation of digital systems in the US.[citation needed] On the other hand, women with dense breasts receive two to three times the amount of radiation during their imaging as dense breasts absorb more X-ray because of the density (difficulty of the X-ray to penetrate dense tissue).[citation needed]
References
- ↑ Galen, Barbara; Staab, Edward; Sullivan, Daniel C.; Pisano, Etta D.. "American College of Radiology Imaging Network: The Digital Mammographic Imaging Screening Trial—An Update". https://imaging.cancer.gov/programs_resources/reports_publications/publications/docs/ReportfromtheBiomedicalImagingProgram.pdf.
- ↑ Pisano, Etta (27 October 2005). "Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening". New England Journal of Medicine (NEJM) 353 (17): 1773–1783. doi:10.1056/NEJMoa052911. PMID 16169887. http://content.nejm.org/cgi/content/full/353/17/1773. Retrieved 11 February 2010.
- ↑ Dershaw, D. David (27 October 2005). "Film or Digital Mammographic Screening?". The New England Journal of Medicine 353 (17): 1846–1847. doi:10.1056/NEJMe058253. PMID 16251541. http://content.nejm.org/cgi/content/full/353/17/1846. Retrieved 11 February 2010.
External links
 |  |
